Pathogenic role of anti-C1q autoantibodies in the development of lupus nephritis - a hypothesis

被引:52
作者
Flierman, Roelof [1 ]
Daha, Mohamed R. [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Nephrol, NL-2333 ZA Leiden, Netherlands
关键词
systemic lupus erythematosus; lupus nephritis; anti-C1q autoantibodies; anti-dsDNA autoantibodies; anti-nucleosome autoantibodies; glomerulonephritis; renal disease;
D O I
10.1016/j.molimm.2006.06.010
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
A substantial proportion of patients with systemic lupus erythematosus (SLE) develop renal inflammatory disease, so-called lupus nephritis (LN). LN is a severe complication of SLE which is strongly associated with the presence of autoantibodies against C1q, the first component of the complement system, and other self-antigens (i.e. against DNA and nucleosomes) as well. In this review, the authors focus on anti-C1q autoantibodies and interpret the available data in order to explain how LN may develop and how anti-C1q autoantibodies contribute to its pathogenesis. (C) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:133 / 138
页数:6
相关论文
共 53 条
[1]
AGNELLO V, 1971, J EXP MED, V134, pS228
[2]
Circulating plasma levels of nucleosomes in patients with systemic lupus erythematosus - Correlation with serum antinucleosome antibody titers and absence of clear association with disease activity [J].
Amoura, Z ;
Piette, JC ;
Chabre, H ;
Cacoub, P ;
Papo, T ;
Wechsler, B ;
Bach, JF ;
Koutouzov, S .
ARTHRITIS AND RHEUMATISM, 1997, 40 (12) :2217-2225
[3]
EVIDENCE FOR THE PRESENCE OF AUTOANTIBODIES TO THE COLLAGEN-LIKE PORTION OF C1Q IN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
ANTES, U ;
HEINZ, HP ;
LOOS, M .
ARTHRITIS AND RHEUMATISM, 1988, 31 (04) :457-464
[4]
Development of anti-dsDNA autoantibodies prior to clinical diagnosis of systemic lupus erythematosus [J].
Arbuckle, MR ;
James, JA ;
Kohlhase, KF ;
Rubertone, MV ;
Dennis, GJ ;
Harley, JB .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2001, 54 (1-2) :211-219
[5]
Development of autoantibodies before the clinical onset of systemic lupus erythematosus [J].
Arbuckle, MR ;
McClain, MT ;
Rubertone, MV ;
Scofield, RH ;
Dennis, GJ ;
James, JA ;
Harley, JB .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (16) :1526-1533
[6]
Lupus glomerulonephritis revisited 2004: Autoimmunity and end-organ damage [J].
Bagavant, H ;
Deshmukh, US ;
Gaskin, F ;
Fu, SM .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2004, 60 (1-2) :52-63
[7]
Lupus nephritis - Discussion [J].
Berden, JHM ;
Madias, NE ;
Broumand, B ;
Klinger, M ;
Sonkodi, S ;
Nayak, KS ;
Hruby, Z .
KIDNEY INTERNATIONAL, 1997, 52 (02) :538-558
[8]
Berden JHM, 2003, NETH J MED, V61, P233
[9]
Bruns A, 2000, ARTHRITIS RHEUM-US, V43, P2307, DOI 10.1002/1529-0131(200010)43:10<2307::AID-ANR19>3.0.CO
[10]
2-J